Cigna (CI) Earnings Analysis
Cigna (CI) next reports earnings on 2026-07-30, consensus EPS 7.6 USD. Last quarter (2026-04-30) it beat with EPS 7.79 USD vs 7.6 USD est (+2.5%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E 12.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CI next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 7.6 USD |
| Revenue estimate | 70.14B |
CI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 7.79 USD | 7.6 USD | +2.5% | Beat |
| 2026-02-05 | 8.08 USD | 7.88 USD | +2.5% | Beat |
| 2025-10-30 | 7.83 USD | 7.64 USD | +2.5% | Beat |
| 2025-07-31 | 7.2 USD | 7.16 USD | +0.6% | Beat |
| 2025-05-02 | 6.74 USD | 6.35 USD | +6.1% | Beat |
| 2025-01-30 | 6.64 USD | 7.84 USD | -15.3% | Miss |
| 2024-10-31 | 7.51 USD | 7.23 USD | +3.9% | Beat |
| 2024-08-01 | 6.72 USD | 6.41 USD | +4.8% | Beat |
Beat rate: 7/8 (88%) over reported quarters with consensus data.
CI valuation and analyst view
| Trailing P/E | 12.01 |
|---|---|
| Trailing EPS | 23.951 USD |
| Price / book | 1.77 |
| Dividend yield | 2.16% |
| Market cap | 76.39B |
| Analyst consensus | Buy (29 buy / 10 hold / 0 sell) |
| Avg price target | 340.92 USD |
Related research pages
Frequently asked questions
When is Cigna (CI)'s next earnings date?
Cigna is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 7.6 USD and revenue estimate of 70.14B.
Did CI beat earnings last quarter?
In its 2026-04-30 report, CI posted EPS of 7.79 USD versus a 7.6 USD estimate — a beat of 2.5%.
What is CI's earnings track record?
Over the last 8 reported quarters with consensus data, CI beat estimates 7 times (88%).
What is CI's current P/E ratio and EPS?
CI trades at a trailing P/E of 12.01 on trailing EPS of 23.950665012420238 USD.
What do analysts rate CI?
Analyst consensus is "Buy" across 39 ratings (1 strong buy, 28 buy, 10 hold, 0 sell, 0 strong sell). Average 12-month price target: 340.92 USD.